Unpublished Data May Point to Link Between Lemtrada and Other Autoimmune Diseases in MS Patients
https://multiplesclerosisnewstoday.com/ ... -diseases/
regardsPreviously unpublished results of clinical trials of Lemtrada (alemtuzumab) appears to contain key information as to why many multiple sclerosis patients who use it develop other autoimmune diseases.
Researchers looked at the immune cell mix after Lemtrada depleted many of those cells. They discovered that certain B-cells repopulate the body earlier than key regulatory T-cells, leading to an imbalanced immune system that is prone to turn on itself.
Although the findings pertained specifically to Lemtrada, they suggest that naturally occurring immune cell imbalance could lead to autoimmune diseases, researchers said.
The insight opens the door to scientists developing ways to counter the imbalance to protect MS patients from additional diseases.